Novo Nordisk's diabetes drug Ozempic may reduce the risk of Alzheimer's disease, study says
Oct 24, 2024
The active ingredient in Ozempic was associated with a 40% to 70% lower risk of a first-time Alzheimer's diagnosis in diabetes patients.
https://www.cnbc.com/2024/10/24/novo-nordisks-ozempic-may-reduce-risk-of-alzheimers-disease-study.html
Respond, make new discussions, see other discussions and customize your news...

To add this website to your home screen:

1. Tap tutorialsPoint

2. Select 'Add to Home screen' or 'Install app'.

3. Follow the on-scrren instructions.

Feedback
FAQ
Privacy Policy
Terms of Service